Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,249
Closed -$14K 896
2017
Q4
$14K Buy
2,249
+964
+75% +$6.74K ﹤0.01% 847
2017
Q3
$10K Hold
1,285
﹤0.01% 830
2017
Q2
$9K Buy
1,285
+330
+35% +$1.97K ﹤0.01% 833
2017
Q1
$7K Buy
+955
New +$9.77K ﹤0.01% 838

Other funds holding VXRT

Wedbush Securities's VXRT Position: Q1 2018 in Review

Wedbush Securities sold out of Vaxart (VXRT) in Q1 2018, closing a stake of 2,249 shares — an estimated $14K sold.

Wedbush Securities first reported a position in VXRT in Q1 2017 and held it in 4 quarters. The position peaked at $14K in Q4 2017. 18 funds tracked by Wall St. Rank hold VXRT as of Q1 2018.

  • Wedbush Securities reported no remaining Vaxart position as of Q1 2018 after selling out during the quarter.
  • Wedbush Securities sold 2,249 Vaxart shares in Q1 2018, an estimated $14K.
  • Wedbush Securities first reported a position in Vaxart in Q1 2017 and held it in 4 quarters.
  • Wedbush Securities's Vaxart position peaked at $14K in Q4 2017.
  • 18 funds tracked by Wall St. Rank held Vaxart as of Q1 2018.

Based on Wedbush Securities's 13F filing for Q1 2018, filed 1 May 2018.